カテゴリー： Market Monitor Global, 世界, 医療/バイオ

タンパク質及びペプチド治療薬の世界市場見通し2023年-2029年

◆英語タイトル：Protein and Peptide Therapeutics Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8612 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：65 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Protein and Peptide Therapeutics Market 調査レポートは次の情報を含め、グローバルにおけるのタンパク質及びペプチド治療薬市場規模と予測を収録しています。・世界のタンパク質及びペプチド治療薬市場：売上、2018年-2023年、2024年-2029年
・世界のタンパク質及びペプチド治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のタンパク質及びペプチド治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「注射式」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

タンパク質及びペプチド治療薬のグローバル主要企業は、Sanofi、 Teva、 Novo Nordisk、 Takeda、 Eli Lilly、 AstraZeneca、 Novartis、 AbbVie、 Ipsen、 Ferring、 Merck、 The Medicines、 J & Jなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、タンパク質及びペプチド治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のタンパク質及びペプチド治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界のタンパク質及びペプチド治療薬市場：タイプ別市場シェア、2022年
・注射式、経口式

世界のタンパク質及びペプチド治療薬市場：用途別、2018年-2023年、2024年-2029年
世界のタンパク質及びペプチド治療薬市場：用途別市場シェア、2022年
・がん、代謝異常、中枢神経系、その他

世界のタンパク質及びペプチド治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界のタンパク質及びペプチド治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるタンパク質及びペプチド治療薬のグローバル売上、2018年-2023年
・主要企業におけるタンパク質及びペプチド治療薬のグローバル売上シェア、2022年
・主要企業におけるタンパク質及びペプチド治療薬のグローバル販売量、2018年-2023年
・主要企業におけるタンパク質及びペプチド治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Sanofi、 Teva、 Novo Nordisk、 Takeda、 Eli Lilly、 AstraZeneca、 Novartis、 AbbVie、 Ipsen、 Ferring、 Merck、 The Medicines、 J & J

*************************************************************

・調査・分析レポートの概要
タンパク質及びペプチド治療薬市場の定義
市場セグメント
世界のタンパク質及びペプチド治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のタンパク質及びペプチド治療薬市場規模
世界のタンパク質及びペプチド治療薬市場規模：2022年 VS 2029年
世界のタンパク質及びペプチド治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのタンパク質及びペプチド治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のタンパク質及びペプチド治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：注射式、経口式
タンパク質及びペプチド治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：がん、代謝異常、中枢神経系、その他
タンパク質及びペプチド治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別タンパク質及びペプチド治療薬市場規模 2022年と2029年
地域別タンパク質及びペプチド治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Sanofi、 Teva、 Novo Nordisk、 Takeda、 Eli Lilly、 AstraZeneca、 Novartis、 AbbVie、 Ipsen、 Ferring、 Merck、 The Medicines、 J & J
...

Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.
This report aims to provide a comprehensive presentation of the global market for Protein and Peptide Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Protein and Peptide Therapeutics. This report contains market size and forecasts of Protein and Peptide Therapeutics in global, including the following market information:
Global Protein and Peptide Therapeutics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Protein and Peptide Therapeutics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Injection Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Protein and Peptide Therapeutics include Sanofi, Teva, Novo Nordisk, Takeda, Eli Lilly, AstraZeneca, Novartis, AbbVie and Ipsen, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Protein and Peptide Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Protein and Peptide Therapeutics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Protein and Peptide Therapeutics Market Segment Percentages, by Type, 2022 (%)
Injection
Oral
Global Protein and Peptide Therapeutics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Protein and Peptide Therapeutics Market Segment Percentages, by Application, 2022 (%)
Cancer
Metabolic Disorders
Central Nervous System
Other
Global Protein and Peptide Therapeutics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Protein and Peptide Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Protein and Peptide Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Protein and Peptide Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
J & J
Outline of Major Chapters:
Chapter 1: Introduces the definition of Protein and Peptide Therapeutics, market overview.
Chapter 2: Global Protein and Peptide Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Protein and Peptide Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Protein and Peptide Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Protein and Peptide Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Protein and Peptide Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Protein and Peptide Therapeutics Overall Market Size
2.1 Global Protein and Peptide Therapeutics Market Size: 2022 VS 2029
2.2 Global Protein and Peptide Therapeutics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Protein and Peptide Therapeutics Players in Global Market
3.2 Top Global Protein and Peptide Therapeutics Companies Ranked by Revenue
3.3 Global Protein and Peptide Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Protein and Peptide Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Protein and Peptide Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Protein and Peptide Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Protein and Peptide Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Protein and Peptide Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Protein and Peptide Therapeutics Market Size Markets, 2022 & 2029
4.1.2 Injection
4.1.3 Oral
4.2 By Type – Global Protein and Peptide Therapeutics Revenue & Forecasts
4.2.1 By Type – Global Protein and Peptide Therapeutics Revenue, 2018-2023
4.2.2 By Type – Global Protein and Peptide Therapeutics Revenue, 2024-2029
4.2.3 By Type – Global Protein and Peptide Therapeutics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Protein and Peptide Therapeutics Market Size, 2022 & 2029
5.1.2 Cancer
5.1.3 Metabolic Disorders
5.1.4 Central Nervous System
5.1.5 Other
5.2 By Application – Global Protein and Peptide Therapeutics Revenue & Forecasts
5.2.1 By Application – Global Protein and Peptide Therapeutics Revenue, 2018-2023
5.2.2 By Application – Global Protein and Peptide Therapeutics Revenue, 2024-2029
5.2.3 By Application – Global Protein and Peptide Therapeutics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Protein and Peptide Therapeutics Market Size, 2022 & 2029
6.2 By Region – Global Protein and Peptide Therapeutics Revenue & Forecasts
6.2.1 By Region – Global Protein and Peptide Therapeutics Revenue, 2018-2023
6.2.2 By Region – Global Protein and Peptide Therapeutics Revenue, 2024-2029
6.2.3 By Region – Global Protein and Peptide Therapeutics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Protein and Peptide Therapeutics Revenue, 2018-2029
6.3.2 US Protein and Peptide Therapeutics Market Size, 2018-2029
6.3.3 Canada Protein and Peptide Therapeutics Market Size, 2018-2029
6.3.4 Mexico Protein and Peptide Therapeutics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Protein and Peptide Therapeutics Revenue, 2018-2029
6.4.2 Germany Protein and Peptide Therapeutics Market Size, 2018-2029
6.4.3 France Protein and Peptide Therapeutics Market Size, 2018-2029
6.4.4 U.K. Protein and Peptide Therapeutics Market Size, 2018-2029
6.4.5 Italy Protein and Peptide Therapeutics Market Size, 2018-2029
6.4.6 Russia Protein and Peptide Therapeutics Market Size, 2018-2029
6.4.7 Nordic Countries Protein and Peptide Therapeutics Market Size, 2018-2029
6.4.8 Benelux Protein and Peptide Therapeutics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Protein and Peptide Therapeutics Revenue, 2018-2029
6.5.2 China Protein and Peptide Therapeutics Market Size, 2018-2029
6.5.3 Japan Protein and Peptide Therapeutics Market Size, 2018-2029
6.5.4 South Korea Protein and Peptide Therapeutics Market Size, 2018-2029
6.5.5 Southeast Asia Protein and Peptide Therapeutics Market Size, 2018-2029
6.5.6 India Protein and Peptide Therapeutics Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Protein and Peptide Therapeutics Revenue, 2018-2029
6.6.2 Brazil Protein and Peptide Therapeutics Market Size, 2018-2029
6.6.3 Argentina Protein and Peptide Therapeutics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Protein and Peptide Therapeutics Revenue, 2018-2029
6.7.2 Turkey Protein and Peptide Therapeutics Market Size, 2018-2029
6.7.3 Israel Protein and Peptide Therapeutics Market Size, 2018-2029
6.7.4 Saudi Arabia Protein and Peptide Therapeutics Market Size, 2018-2029
6.7.5 UAE Protein and Peptide Therapeutics Market Size, 2018-2029
7 Protein and Peptide Therapeutics Companies Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Protein and Peptide Therapeutics Major Product Offerings
7.1.4 Sanofi Protein and Peptide Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Sanofi Key News & Latest Developments
7.2 Teva
7.2.1 Teva Company Summary
7.2.2 Teva Business Overview
7.2.3 Teva Protein and Peptide Therapeutics Major Product Offerings
7.2.4 Teva Protein and Peptide Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Teva Key News & Latest Developments
7.3 Novo Nordisk
7.3.1 Novo Nordisk Company Summary
7.3.2 Novo Nordisk Business Overview
7.3.3 Novo Nordisk Protein and Peptide Therapeutics Major Product Offerings
7.3.4 Novo Nordisk Protein and Peptide Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Novo Nordisk Key News & Latest Developments
7.4 Takeda
7.4.1 Takeda Company Summary
7.4.2 Takeda Business Overview
7.4.3 Takeda Protein and Peptide Therapeutics Major Product Offerings
7.4.4 Takeda Protein and Peptide Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Takeda Key News & Latest Developments
7.5 Eli Lilly
7.5.1 Eli Lilly Company Summary
7.5.2 Eli Lilly Business Overview
7.5.3 Eli Lilly Protein and Peptide Therapeutics Major Product Offerings
7.5.4 Eli Lilly Protein and Peptide Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Eli Lilly Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Protein and Peptide Therapeutics Major Product Offerings
7.6.4 AstraZeneca Protein and Peptide Therapeutics Revenue in Global Market (2018-2023)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 Novartis
7.7.1 Novartis Company Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Protein and Peptide Therapeutics Major Product Offerings
7.7.4 Novartis Protein and Peptide Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Novartis Key News & Latest Developments
7.8 AbbVie
7.8.1 AbbVie Company Summary
7.8.2 AbbVie Business Overview
7.8.3 AbbVie Protein and Peptide Therapeutics Major Product Offerings
7.8.4 AbbVie Protein and Peptide Therapeutics Revenue in Global Market (2018-2023)
7.8.5 AbbVie Key News & Latest Developments
7.9 Ipsen
7.9.1 Ipsen Company Summary
7.9.2 Ipsen Business Overview
7.9.3 Ipsen Protein and Peptide Therapeutics Major Product Offerings
7.9.4 Ipsen Protein and Peptide Therapeutics Revenue in Global Market (2018-2023)
7.9.5 Ipsen Key News & Latest Developments
7.10 Ferring
7.10.1 Ferring Company Summary
7.10.2 Ferring Business Overview
7.10.3 Ferring Protein and Peptide Therapeutics Major Product Offerings
7.10.4 Ferring Protein and Peptide Therapeutics Revenue in Global Market (2018-2023)
7.10.5 Ferring Key News & Latest Developments
7.11 Merck
7.11.1 Merck Company Summary
7.11.2 Merck Business Overview
7.11.3 Merck Protein and Peptide Therapeutics Major Product Offerings
7.11.4 Merck Protein and Peptide Therapeutics Revenue in Global Market (2018-2023)
7.11.5 Merck Key News & Latest Developments
7.12 The Medicines
7.12.1 The Medicines Company Summary
7.12.2 The Medicines Business Overview
7.12.3 The Medicines Protein and Peptide Therapeutics Major Product Offerings
7.12.4 The Medicines Protein and Peptide Therapeutics Revenue in Global Market (2018-2023)
7.12.5 The Medicines Key News & Latest Developments
7.13 J & J
7.13.1 J & J Company Summary
7.13.2 J & J Business Overview
7.13.3 J & J Protein and Peptide Therapeutics Major Product Offerings
7.13.4 J & J Protein and Peptide Therapeutics Revenue in Global Market (2018-2023)
7.13.5 J & J Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Protein and Peptide Therapeutics Market Opportunities & Trends in Global Market
Table 2. Protein and Peptide Therapeutics Market Drivers in Global Market
Table 3. Protein and Peptide Therapeutics Market Restraints in Global Market
Table 4. Key Players of Protein and Peptide Therapeutics in Global Market
Table 5. Top Protein and Peptide Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Protein and Peptide Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Protein and Peptide Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Protein and Peptide Therapeutics Product Type
Table 9. List of Global Tier 1 Protein and Peptide Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Protein and Peptide Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Protein and Peptide Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Protein and Peptide Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Protein and Peptide Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Protein and Peptide Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Protein and Peptide Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Protein and Peptide Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Protein and Peptide Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Protein and Peptide Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Protein and Peptide Therapeutics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Protein and Peptide Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Protein and Peptide Therapeutics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Protein and Peptide Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Protein and Peptide Therapeutics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Protein and Peptide Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Protein and Peptide Therapeutics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Protein and Peptide Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Protein and Peptide Therapeutics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Protein and Peptide Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Protein and Peptide Therapeutics Revenue, (US$, Mn), 2024-2029
Table 30. Sanofi Company Summary
Table 31. Sanofi Protein and Peptide Therapeutics Product Offerings
Table 32. Sanofi Protein and Peptide Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. Sanofi Key News & Latest Developments
Table 34. Teva Company Summary
Table 35. Teva Protein and Peptide Therapeutics Product Offerings
Table 36. Teva Protein and Peptide Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. Teva Key News & Latest Developments
Table 38. Novo Nordisk Company Summary
Table 39. Novo Nordisk Protein and Peptide Therapeutics Product Offerings
Table 40. Novo Nordisk Protein and Peptide Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. Novo Nordisk Key News & Latest Developments
Table 42. Takeda Company Summary
Table 43. Takeda Protein and Peptide Therapeutics Product Offerings
Table 44. Takeda Protein and Peptide Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. Takeda Key News & Latest Developments
Table 46. Eli Lilly Company Summary
Table 47. Eli Lilly Protein and Peptide Therapeutics Product Offerings
Table 48. Eli Lilly Protein and Peptide Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. Eli Lilly Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Protein and Peptide Therapeutics Product Offerings
Table 52. AstraZeneca Protein and Peptide Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Novartis Company Summary
Table 55. Novartis Protein and Peptide Therapeutics Product Offerings
Table 56. Novartis Protein and Peptide Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 57. Novartis Key News & Latest Developments
Table 58. AbbVie Company Summary
Table 59. AbbVie Protein and Peptide Therapeutics Product Offerings
Table 60. AbbVie Protein and Peptide Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 61. AbbVie Key News & Latest Developments
Table 62. Ipsen Company Summary
Table 63. Ipsen Protein and Peptide Therapeutics Product Offerings
Table 64. Ipsen Protein and Peptide Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 65. Ipsen Key News & Latest Developments
Table 66. Ferring Company Summary
Table 67. Ferring Protein and Peptide Therapeutics Product Offerings
Table 68. Ferring Protein and Peptide Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 69. Ferring Key News & Latest Developments
Table 70. Merck Company Summary
Table 71. Merck Protein and Peptide Therapeutics Product Offerings
Table 72. Merck Protein and Peptide Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 73. Merck Key News & Latest Developments
Table 74. The Medicines Company Summary
Table 75. The Medicines Protein and Peptide Therapeutics Product Offerings
Table 76. The Medicines Protein and Peptide Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 77. The Medicines Key News & Latest Developments
Table 78. J & J Company Summary
Table 79. J & J Protein and Peptide Therapeutics Product Offerings
Table 80. J & J Protein and Peptide Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 81. J & J Key News & Latest Developments
List of Figures
Figure 1. Protein and Peptide Therapeutics Segment by Type in 2022
Figure 2. Protein and Peptide Therapeutics Segment by Application in 2022
Figure 3. Global Protein and Peptide Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Protein and Peptide Therapeutics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Protein and Peptide Therapeutics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Protein and Peptide Therapeutics Revenue in 2022
Figure 8. By Type - Global Protein and Peptide Therapeutics Revenue Market Share, 2018-2029
Figure 9. By Application - Global Protein and Peptide Therapeutics Revenue Market Share, 2018-2029
Figure 10. By Type - Global Protein and Peptide Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Protein and Peptide Therapeutics Revenue Market Share, 2018-2029
Figure 12. By Application - Global Protein and Peptide Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Protein and Peptide Therapeutics Revenue Market Share, 2018-2029
Figure 14. By Region - Global Protein and Peptide Therapeutics Revenue Market Share, 2018-2029
Figure 15. By Country - North America Protein and Peptide Therapeutics Revenue Market Share, 2018-2029
Figure 16. US Protein and Peptide Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Protein and Peptide Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Protein and Peptide Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Protein and Peptide Therapeutics Revenue Market Share, 2018-2029
Figure 20. Germany Protein and Peptide Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 21. France Protein and Peptide Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Protein and Peptide Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Protein and Peptide Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Protein and Peptide Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Protein and Peptide Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Protein and Peptide Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Protein and Peptide Therapeutics Revenue Market Share, 2018-2029
Figure 28. China Protein and Peptide Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Protein and Peptide Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Protein and Peptide Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Protein and Peptide Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 32. India Protein and Peptide Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Protein and Peptide Therapeutics Revenue Market Share, 2018-2029
Figure 34. Brazil Protein and Peptide Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Protein and Peptide Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Protein and Peptide Therapeutics Revenue Market Share, 2018-2029
Figure 37. Turkey Protein and Peptide Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Protein and Peptide Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Protein and Peptide Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Protein and Peptide Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 41. Sanofi Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Teva Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novo Nordisk Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Takeda Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Eli Lilly Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. AstraZeneca Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Novartis Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. AbbVie Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Ipsen Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Ferring Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Merck Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. The Medicines Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. J & J Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ タンパク質及びペプチド治療薬の世界市場見通し2023年-2029年(Protein and Peptide Therapeutics Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

タンパク質及びペプチド治療薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp